MXPA04002103A - Una proteina de union a caspasa-8, su preparacion y uso. - Google Patents

Una proteina de union a caspasa-8, su preparacion y uso.

Info

Publication number
MXPA04002103A
MXPA04002103A MXPA04002103A MXPA04002103A MXPA04002103A MX PA04002103 A MXPA04002103 A MX PA04002103A MX PA04002103 A MXPA04002103 A MX PA04002103A MX PA04002103 A MXPA04002103 A MX PA04002103A MX PA04002103 A MXPA04002103 A MX PA04002103A
Authority
MX
Mexico
Prior art keywords
caspase
preparation
binding protein
cari
methods
Prior art date
Application number
MXPA04002103A
Other languages
English (en)
Inventor
Kolumam Ganesh
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14527801A external-priority patent/IL145278A0/xx
Priority claimed from IL14625101A external-priority patent/IL146251A0/xx
Priority claimed from IL14748702A external-priority patent/IL147487A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of MXPA04002103A publication Critical patent/MXPA04002103A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Abstract

La presente invencion se refiere a un polipeptido que interacciona con caspasa-8 (Cari) a metodos para su preparacion y su uso.
MXPA04002103A 2001-09-04 2002-09-04 Una proteina de union a caspasa-8, su preparacion y uso. MXPA04002103A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL14527801A IL145278A0 (en) 2001-09-04 2001-09-04 A caspase-8 binding protein, its preparation and use
IL14625101A IL146251A0 (en) 2001-09-04 2001-10-31 A caspase-8 binding protein, its preparation and use
IL14748702A IL147487A0 (en) 2002-01-06 2002-01-06 A caspase-8 binding protein, its preparation and use
PCT/IL2002/000733 WO2003020759A2 (en) 2001-09-04 2002-09-04 A caspase- 8 binding protein, its preparation and use

Publications (1)

Publication Number Publication Date
MXPA04002103A true MXPA04002103A (es) 2004-06-07

Family

ID=27271952

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002103A MXPA04002103A (es) 2001-09-04 2002-09-04 Una proteina de union a caspasa-8, su preparacion y uso.

Country Status (10)

Country Link
US (2) US7354736B2 (es)
EP (1) EP1423422A2 (es)
JP (1) JP2005501545A (es)
KR (1) KR20040049845A (es)
CN (1) CN1630664A (es)
BR (1) BR0212287A (es)
CA (1) CA2459136A1 (es)
EA (1) EA009956B1 (es)
MX (1) MXPA04002103A (es)
WO (1) WO2003020759A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009535060A (ja) 2006-05-03 2009-10-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 単一ナノクレセントｓｅｒｓプローブを使用したプロテアーゼおよびプロテアーゼ活性の検出
EP2043678B1 (en) * 2006-06-28 2012-09-12 Yeda Research and Development Co. Ltd Caspase-8 and inflammation, infection and wound healing
US8150192B2 (en) * 2006-11-27 2012-04-03 Merge Cad Inc. System and method for feature score mapping and visualization of medical images
CA2679643A1 (en) * 2007-03-09 2008-09-18 The University Of British Columbia Procaspase 8-mediated disease targeting
BRPI0920546B1 (pt) 2008-10-08 2021-08-10 Cambridge Enterprise Limited Métodos para identificar e selecionar um paciente com esclerose múltipla
MA37681B2 (fr) 2012-05-25 2020-07-29 Cellectis Procédés pour modifier des lymphocytes t résistants allogéniques et immunosuppresseurs pour l'immunothérapie
CN104769103B (zh) * 2012-09-04 2018-06-08 塞勒克提斯公司 多链嵌合抗原受体和其用途
RU2671510C1 (ru) * 2016-06-29 2018-11-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ выделения белкового высокомолекулярного комплекса активации каспазы-2 человека
KR102447083B1 (ko) 2016-10-06 2022-09-26 포세이다 테라퓨틱스, 인크. 유도성 카스파제 및 사용 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5958698A (en) * 1997-01-09 1998-08-03 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
IL132105A0 (en) * 1998-12-24 2001-03-19 Yeda Res & Dev Caspase-8 interacting proteins
US20040101927A9 (en) * 2000-01-31 2004-05-27 Rosen Craig A. Nucleic acids, proteins, and antibodies

Also Published As

Publication number Publication date
WO2003020759A9 (en) 2003-12-31
US7354736B2 (en) 2008-04-08
CA2459136A1 (en) 2003-03-13
EA009956B1 (ru) 2008-04-28
EA200400392A1 (ru) 2004-10-28
BR0212287A (pt) 2004-09-14
KR20040049845A (ko) 2004-06-12
JP2005501545A (ja) 2005-01-20
WO2003020759A3 (en) 2003-11-27
EP1423422A2 (en) 2004-06-02
WO2003020759A2 (en) 2003-03-13
CN1630664A (zh) 2005-06-22
US20080254028A1 (en) 2008-10-16
US20050048639A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
YU68002A (sh) Modifikovani faktor viii
IL161016A (en) Polypeptides capable of ang-2 binding
IL200404A0 (en) 191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
DE60120712D1 (en) Kallikrein gen
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
AU2001295483A1 (en) Solid peptide preparations for inhalation, and the production thereof
ZA200205408B (en) Process for the preparation of peptides.
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2002356522A1 (en) Polynucleotide encoding adapter protein, pmn29
IL150458A0 (en) Novel haptotactic peptides
AU2002220924A1 (en) Antibodies, peptides, analogs and uses thereof
HK1082510A1 (en) Promoter to il-18bp, its preparation and use
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
WO2003020767A3 (en) Antibodies against caspase-8, their preparation and use
AU2002356339A1 (en) Soluble recombinant protein production
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen
AU8748101A (en) A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
EP1392340A4 (en) CYTOTOXIC PEPTIDES, PEPTIDOMIMETICS BASED ON THESE PEPTIDES, AND METHODS OF USE
AU2002257361A1 (en) Peptide beta-strand mimics based on 1,2-dihydro-3(6h)-pyridinone
AU8557801A (en) Modified proteins, isolated novel peptides, and uses thereof
AU2002328922A1 (en) System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal